Valuation (34%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -9.26 | 60.87 |
| PEG Ratio (TTM) | -0.41 | 5.39 |
| P/S Ratio (TTM) | 1.03 | 19.62 |
| P/B Ratio (TTM) | 0.47 | 26.98 |
| P/FCF Ratio (TTM) | -5.79 | 55.99 |
| Price to 5YR AVG Earnings Ratio | 27.68 | 172.73 |
| Price to 5YR AVG FCF Ratio | -4.86 | 179.40 |
Profitability (3%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.86% | 33.23% |
| ROE (TTM) | -5.04% | 61.15% |
| Net Profit Margin (TTM) | -10.73% | 32.43% |
| ROIC 5YR AVG | 0.33% | 31.31% |
Growth (70%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 3.34% | 158.85% | 53.75% |
| Revenue | 9.11% | 13.31% | -0.73% |
| Net Income | 3.44% | 163.37% | 57.10% |
| Cash Flow | -267.26% | 27.78% | 11.39% |
Health (33%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.13 | 3.13 |
| Quick Ratio (TTM) | 1.04 | 2.68 |
| D/E Ratio (TTM) | 0.27 | 0.34 |
| Interest Coverage (TTM) | -8.68 | 169.39 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | 1.00 | 35.13 |
| LTL to 5YR AVG FCF | -0.12 | -0.50 |
| Shares Outstanding Growth 5YR AVG | 1.78% | 30.11% |